West Pharmaceutical Services (WST)
Stock-Based Compensation
$32.60M
TTM · Period ending: · USD
WST Stock-Based Compensation
Latest reported$32.60Mperiod ending
Latest reported$32.60Mperiod ending
WST TTM Stock-Based Comp ($0.00 → $32.60M)
TTM stock-based compensation
High-resolution chart · PNG
WST stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 32,600,000 | |
| 29,100,000 | |
| 23,800,000 | |
| 21,400,000 | |
| 18,100,000 | |
| 15,000,000 | |
| 18,700,000 | |
| 15,800,000 | |
| 16,600,000 | |
| 19,800,000 | |
| 23,300,000 | |
| 28,600,000 | |
| 28,700,000 | |
| 26,700,000 | |
| 23,700,000 | |
| 27,000,000 | |
| 32,300,000 | |
| 37,100,000 | |
| 37,500,000 | |
| 33,900,000 | |
| 32,500,000 | |
| 34,500,000 | |
| 34,000,000 | |
| 33,200,000 | |
| 28,700,000 | |
| 23,600,000 | |
| 24,400,000 | |
| 19,200,000 | |
| 19,100,000 | |
| 17,900,000 | |
| 15,100,000 | |
| 17,200,000 | |
| 16,500,000 | |
| 16,000,000 | |
| 16,100,000 | |
| 19,000,000 | |
| 19,000,000 | |
| 18,400,000 | |
| 19,500,000 | |
| 19,300,000 | |
| 18,300,000 | |
| 28,900,000 | |
| 29,600,000 | |
| 30,500,000 | |
| 30,500,000 | |
| 19,600,000 | |
| 18,600,000 | |
| 18,100,000 | |
| 19,700,000 | |
| 20,100,000 | |
| 21,200,000 | |
| 19,300,000 | |
| 14,100,000 | |
| 9,100,000 | |
| 3,700,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,600,000 | |
| -1,600,000 | |
| -1,600,000 | |
| -1,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |